Rhythmic Auditory Stimulation for Parkinson's Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how rhythmic auditory stimulation (RAS) can help people with Parkinson's disease improve their walking. Participants will walk to metronome beats while researchers study their walking patterns and brain activity, both with their usual brain stimulation device turned on and off. The goal is to determine if RAS can make walking easier and more stable. This trial is for individuals diagnosed with Parkinson’s disease who have a specific type of brain implant, known as Deep Brain Stimulation (DBS). As an unphased trial, it offers a unique opportunity to contribute to innovative research that could enhance mobility for Parkinson's patients.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that Rhythmic Auditory Stimulation is safe for Parkinson's Disease patients?
Research has shown that Rhythmic Auditory Stimulation (RAS) is generally safe and easy to manage. One study found that RAS effectively improves walking patterns, such as step length and speed, without causing harmful side effects. Another study confirmed that RAS is non-invasive, meaning it does not harm health. It uses rhythmic sounds, like music, to help coordinate movements, making it a promising technique for those needing assistance with walking. Overall, RAS is considered a safe option for improving movement issues.12345
Why are researchers excited about this trial?
Researchers are excited about Rhythmic Auditory Stimulation (RAS) for Parkinson's disease because it offers a novel approach by using sound to potentially improve motor functions. Unlike standard treatments that typically rely on medication to manage symptoms, RAS uses metronome beats to help improve walking patterns. By synchronizing movements to rhythmic cues, this method might enhance gait stability and speed, providing a non-invasive alternative to traditional therapies. This could offer a new way to manage Parkinson's symptoms, especially for those seeking non-pharmaceutical options.
What evidence suggests that Rhythmic Auditory Stimulation is effective for improving gait in Parkinson's Disease?
Research shows that Rhythmic Auditory Stimulation (RAS) can improve movement in people with Parkinson's disease. In this trial, participants will use RAS during walking exercises. Studies have found that this can lengthen and quicken steps, enhancing walking ability. RAS also aids balance and overall movement by using rhythmic sounds, like metronome beats, to help the brain coordinate movement more effectively. Consequently, many patients find they can walk better and manage daily activities more easily.13467
Who Is on the Research Team?
Alexander Pantelyat, MD
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
This trial is for Parkinson's Disease patients who have had a Deep Brain Stimulation (DBS) device implanted. Participants should be able to follow study directions and must already be using the PerceptTM PC with their DBS.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-RAS Assessment
Participants undergo assessments to measure gait parameters and patterns during stimulation ON and OFF using the 10-meter walk and MDS-UPDRS-III rating scale.
RAS Treatment
Participants walk to the metronome beats for four minutes, and gait parameters are recorded. Electrophysiological activity is collected.
Post-RAS Assessment
The same assessment as the Pre-RAS is conducted to measure changes in gait parameters and patterns.
Follow-up
Participants are monitored for safety and effectiveness after treatment.
What Are the Treatments Tested in This Trial?
Interventions
- Rhythmic Auditory Stimulation (RAS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor